Company Information
Industry 制造业
Company Introduction 山东东阿阿胶股份有限公司是一家以阿胶及相关产品生产和销售为主的企业.公司主要经营范围:许可证范围内的胶剂、口服液、合剂、煎膏剂、颗粒剂、硬胶囊剂、糖浆剂等药品的生产、销售;批准范围内的商品进出口业务;许可证范围内保健食品的生产、销售。公司是是中国最大的阿胶企业,阿胶行业标准制定者,山东省拥有生物药最多的企业。东阿阿胶坚持质量、品牌、效益发展模式,3次荣获国家质量奖金奖,获传统药“长城”国际金奖、中国质量奖提名奖,山东省首届省长质量奖,为“中国500最具价值品牌”。 公司以“寿人济世”为使命,秉持“厚道地道传承创新”的核心价值观,坚守“为品质立信、为团队立志、为行业立范、为生民立命、为民族立魂”的承诺,以“大众最信赖的滋补健康引领者”为愿景,以客户需求与体验为关注焦点,持续巩固“滋补国宝东阿阿胶”顶流品牌,不断汲取三千年中医药传统文化和滋补养生精粹,持续坚定以科技创新和严格的全产业链质量管控提升阿胶品质,致力于打造具有中华民族特色和国际视野的滋补行业引领品牌。
Main Business 阿胶和阿胶系列及其他中成药等产品的研发、生产和销售。
Legal Representative 孙金妮
Top Executives
董事长:程杰
董事:于晓辉,王小跃,徐培清,孙金妮,丁红岩,程杰
独立董事:孙晓波,果德安,文光伟
Top 5 Shareholder
Shareholder name Nature Holding Date
华润东阿阿胶有限公司流通A股23.50%30/06/2025
华润医药投资有限公司流通A股10.19%30/06/2025
香港中央结算有限公司流通A股9.35%30/06/2025
交银施罗德基金-中国人寿保险股份有限公司-分红险-交银施罗德基金国寿股份均衡股票型组合单一资产管理计划(可供出售)流通A股1.64%30/06/2025
交银施罗德基金-中国人寿保险股份有限公司-传统险-交银施罗德国寿股份均衡股票传统可供出售单一资产管理计划流通A股1.36%30/06/2025
Company Secretary 丁红岩
Solicitors 华堂律师事务所
Auditors 山东会计师事务所
Tel No 0531-88800423
Fax No 0531-88800423
Website www.dongeejiao.com
Email irm@dongeejiao.com;dinghongyan1@dongeejiao.com;fuyan@dongeejiao.com;deejdb@dongeejiao.com
Company Address
Register: 山东省聊城市东阿县阿胶街78号
Office: 山东省聊城市东阿县阿胶街78号
Listing Date 29/07/1996
Shares Capital
Shares Capital: 643,976,824
Total A Share: 643,976,824
Listed A Share: 643,018,085
Non-tradable A Share: 958,739
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 2.420
DPS(RMB)* ¥ 2.420
NBV Per Share(RMB)* ¥ 16.010
Market Capitalization(RMB) 30.621B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.